• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

MiniMed launches Instinct sensors made by Abbott with insulin delivery tech in Europe

June 23, 2026 By Sean Whooley

MiniMed 780G and Go systems lifestyle pics with Instinct sensor made by Abbott
The 780G pump with Instinct (left) and Go smart MDI system with Instinct Go (right). [Images courtesy of MiniMed]
MiniMed (Nasdaq:MMED) announced today that it launched two insulin delivery platforms with the Instinct sensor made by Abbott in Europe.

The Northridge, California-based former Medtronic Diabetes unit launched its MiniMed 780G automated insulin delivery system integrated with Instinct, along with the MiniMed Go system paired with the Instinct Go sensor. Both sensors, made by Abbott and offered by Medtronic through a collaboration between the companies, will be gradually rolled out across Europe beginning this month.

MiniMed said the launch further expands its glucose sensing and diabetes management portfolio in the region. It follows launches of both integrated offerings in the U.S. in recent months, with 780G and Instinct rolling out in December 2025, followed by Go’s launch last month.

When paired with MiniMed 780G, Medtronic’s latest-generation automated insulin delivery system, Instinct provides real-time glucose readings, helping the pump automate insulin adjustments every five minutes. The system also offers meal detection technology and provides automatic adjustments and corrections to sugar levels every five minutes. This occurs for both basal (background) and bolus (mealtime) insulin needs.

MiniMed Go, a connected smart multiple daily injection (MDI) system, integrates the InPen smart insulin pen with Instinct Go. It all integrates within a mobile app to deliver real-time, personalized insights and actionable guidance. The platform targets people living with diabetes who manage their condition using MDI, simplifying insulin management without adding complexity to daily life.

The company won FDA clearance for the integrated offering in January.

Que Dallara, CEO of MiniMed, said:

“People with diabetes should not have to choose between flexibility and performance when managing their diabetes — and with MiniMed, they don’t have to. Expanding our sensor portfolio across Europe with Instinct and Instinct Go means more people can access the proven outcomes, intelligent insights, and seamless automation MiniMed is known for. This is about meeting people where they are and building technology that fits their life — not the other way around. That’s what drives us every day.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: minimed

IN CASE YOU MISSED IT

  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS